Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (326)
ARTG (261)
Prescription medicine registration (29)
Prescription medicine evaluation (3)
Designation or determination (2)

Date

2026 (47)
2025 (31)
2024 (51)
2023 (161)
2022 (30)
2021 (31)
2020 (45)
2019 (26)
2018 (50)
2017 (35)
2016 (77)
2015 (2)
2014 (1)
2013 (5)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

621 result(s) found, displaying 491 to 500

PALSET palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial (237483)

13 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PALSET palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial.
PRICELINE CETIRIZINE cetirizine hydrochloride 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACY CHOICE FEXOFENADINE fexofenadine hydrochloride 120mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PRICELINE FEXOFENADINE fexofenadine hydrochloride 180mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACY HEALTH fexofenadine hydrochloride 180mg film-coated tablet blister pack new formulation Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACY CHOICE FEXOFENADINE fexofenadine hydrochloride 180mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TERRY WHITE CHEMISTS FEXOFENADINE fexofenadine hydrochloride 180mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PANTOFAST pantoprazole (as sodium sesquihydrate) 20 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
DONEPEZIL-DRLA donepezil hydrochloride (as monohydrate) 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ESCITALOPRAM-DRLA escitalopram (as oxalate) 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 46
Page 47
Page 48
Page 49
Current page 50
Page 51
Page 52
Page 53
Page 54
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.